Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects

NCT01205867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Butyrylcholinesterase Deficiency

Interventions

DRUG: AZD8848

Sponsor

AstraZeneca